Efficacy of JAK STAT Pathways Inhibitors in Treatment of Patients With Rheumatoid Arthritis

NCT05788705 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

75

Enrollment

OTHER

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DIETARY_SUPPLEMENT: "apigenin" and "glycyrrhizin"
DIETARY_SUPPLEMENT: "glycyrrhizin" and "boswellic acid"
DIETARY_SUPPLEMENT: "placebo"

Sponsor

Adel A.Gomaa